Welcome
Support Centre
11 February 2012 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
mental health register
archived registers
all registers
tips on searching
 
 
Information
about mRCT
mRCT FAQs

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
A Study of the Prevention of Alloimmunisation using Leukocyte-Depleted Red Cell and Platelet Donations
Source of recordUK Trials
ISRCTNISRCTN43344383
Date ISRCTN assigned19/08/2002
Local reference number(s)LK/FIL
Public titleA Study of the Prevention of Alloimmunisation using Leukocyte-Depleted Red Cell and Platelet Donations
Scientific title
AcronymN/A
Disease/condition/study domainLeukaemia (acute), Leukaemia (chronic)
Study hypothesisNot provided at time of registration
Design/methodologyRandomised controlled trial
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteria1. Patients with acute leukaemia, chronic myeloid leukaemia, severe aplastic anaemia or high grade lymphoma
2. Patients already known to have Human Leukocyte Antigens (HLA) antibodies or recurrent febrile transfusion reactions are ineligible
3. Any age
4. Fit to undergo the treatments as defined in protocol
Participants - exclusion criteriaNot provided at time of registration
Patient information material
Anticipated end date01/04/1992
Status of trialCompleted
Target number of participantsNot provided at time of registration
InterventionsPatients are randomised to one of two treatment arms:
1. Arm A: Patients receive standard non-filtered, non-leukocyte-depleted blood products.
2. Arm B: Patients receive Pall filtered blood or platelet donations.
Primary outcome measure(s)Not provided at time of registration
Secondary outcome measure(s)Not provided at time of registration
Sources of fundingPall Biomedical Ltd
Sponsor namePall Biomedical Ltd
Sponsor details
Portsmouth
United Kingdom
Contact nameDr - -
Contact detailsUKCCCR Register Co-ordinator
MRC Clinical Trials Unit
222 Euston Road
London
United Kingdom
NW1 2DA
Contact telephone+44 (0) 20 7670 4723
Contact fax+44 (0) 20 7670 4818
Contact emailregister@ctu.mrc.ac.uk
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN43344383
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 Current Controlled Trials Ltd. Part of Springer Science+Business Media. | terms & conditions | privacy statement


BioMed Central